The complicated task of monitoring vaccine safety.

Vaccination is an essential component of modern public health programs and is among our most cost-effective medical interventions. Yet despite vaccines' clear effectiveness in reducing risks of diseases that previously attacked large proportions of the population, caused many deaths, and left many people with permanent disabilities, current vaccination policies are not without controversy. Vaccines, like all other pharmaceutical products, are not entirely risk-free; while most known side effects are minor and self-limited, some vaccines have been associated with very rare but serious adverse effects. Because such rare effects are often not evident until vaccines come into widespread use, the Federal government maintains ongoing surveillance programs to monitor vaccine safety. The interpretation of data from such programs is complex and is associated with substantial uncertainty. A continual effort to monitor these data effectively and to develop more precise ways of assessing risks of vaccines is necessary to ensure public confidence in immunization programs.

[1]  T. Dwyer,et al.  Factors potentiating the risk of sudden infant death syndrome associated with the prone position. , 1993, The New England journal of medicine.

[2]  H. Fineberg,et al.  Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines , 1991 .

[3]  B. P. Lewis,et al.  Combined Vaccines and Simultaneous Administration: Current Issues and Perspectives. Conference proceedings. Bethesda, Maryland, July 28-30, 1993. , 1995, Annals of the New York Academy of Sciences.

[4]  D. Nalin.  Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994, The Yale Journal of Biology and Medicine.

[5]  P. Strebel,et al.  Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. , 1994, Archives of pediatrics & adolescent medicine.

[6]  S. Rosenthal,et al.  The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. , 1996, Archives of pediatrics & adolescent medicine.

[7]  I. Krantz,et al.  Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. , 1989, International journal of epidemiology.

[8]  H. Fineberg,et al.  Adverse Effects of Pertussis and Rubella Vaccines , 1991 .

[9]  J. Golding,et al.  Can the fall in Avon's sudden infant death rate be explained by changes in sleeping position? , 1992, BMJ.

[10]  S. Rosenthal,et al.  The reporting sensitivities of two passive surveillance systems for vaccine adverse events. , 1995, American journal of public health.

[11]  E. Larson.  Food and Drug Administration Approval of Use of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine , 1992, Infection Control & Hospital Epidemiology.

[12]  S. Ellenberg,et al.  Syncope after immunization. , 1997, Archives of pediatrics & adolescent medicine.

[13]  J. Wadsworth,et al.  Pertussis immunisation and serious acute neurological illnesses in children. , 1993, BMJ.

[14]  R. Thompson,et al.  Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. , 1987, American journal of public health.

[15]  R. Waldman,et al.  Textbook of infectious diseases , 1984 .

[16]  S. Cochi,et al.  The Vaccine Adverse Event Reporting System (VAERS). , 1994, Vaccine.

[17]  H. Hoffman,et al.  Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. , 1992, Clinics in perinatology.

[18]  W. Guntheroth,et al.  Recommendations to avoid the prone sleeping position and recent statistics for sudden infant death syndrome in the United States. , 1994, Archives of pediatrics & adolescent medicine.

[19]  E. Mitchell,et al.  Reduction in mortality from sudden infant death syndrome in New Zealand: 1986-92. , 1994, Archives of disease in childhood.

[20]  G. Faich,et al.  Adverse-drug-reaction monitoring. , 1986, The New England journal of medicine.

[21]  S. Edelstein,et al.  The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. , 1995, JAMA.

[22]  A. Hinman,et al.  Monitoring system for adverse events following immunization. , 1987, Vaccine.

[23]  M. Willinger.  Sleep position and sudden infant death syndrome. , 1995, JAMA.

[24]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .

[25]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[26]  B. Strom,et al.  Use of automated databases for pharmacoepidemiology research. , 1990, Epidemiologic reviews.

[27]  S. Ellenberg,et al.  Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. , 1996, The Pediatric Infectious Disease Journal.

[28]  H. Kuno-sakai,et al.  Developments in pertussis immunisation in Japan , 1990, The Lancet.

[29]  A. Hinman.  DTP vaccine litigation. , 1986, American journal of diseases of children.

[30]  F. Varricchio,et al.  Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). , 1996, The Pediatric infectious disease journal.

[31]  P. Strebel,et al.  Recommended Childhood Immunization Schedule , 1995, Clinical pediatrics.

[32]  T. Dwyer,et al.  The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. , 1995, JAMA.